RCM
ABBV icon

Raleigh Capital Management’s AbbVie ABBV Stock Holding History

Raleigh Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.34M Buy
15,361
+176
+1% +$39K 1.15% 16
2025
Q4 		$3.47M Sell
15,185
-1,659
-10% -$378K 1.26% 12
2025
Q3 		$3.9M Buy
16,844
+193
+1% +$39.3K 1.48% 8
2025
Q2 		$3.09M Buy
16,651
+1,446
+10% +$269K 1.3% 10
2025
Q1 		$3.19M Buy
15,205
+545
+4% +$106K 1.44% 9
2024
Q4 		$2.61M Buy
14,660
+2,608
+22% +$479K 1% 16
2024
Q3 		$2.38M Sell
12,052
-162
-1% -$30.2K 0.92% 18
2024
Q2 		$2.09M Sell
12,214
-769
-6% -$127K 0.89% 22
2024
Q1 		$2.36M Sell
12,983
-4,239
-25% -$731K 1.02% 16
2023
Q4 		$2.67M Buy
17,222
+647
+4% +$94.3K 1.24% 15
2023
Q3 		$2.47M Buy
16,575
+143
+0.9% +$21K 1.26% 13
2023
Q2 		$2.21M Sell
16,432
-2,658
-14% -$390K 1.1% 19
2023
Q1 		$3.04M Buy
19,090
+587
+3% +$89.7K 1.51% 8
2022
Q4 		$2.99M Buy
18,503
+821
+5% +$126K 1.56% 10
2022
Q3 		$2.37M Buy
17,682
+1,379
+8% +$198K 1.39% 11
2022
Q2 		$2.5M Sell
16,303
-1,726
-10% -$264K 1.42% 11
2022
Q1 		$2.92M Buy
18,029
+1,872
+12% +$272K 1.58% 9
2021
Q4 		$2.19M Buy
+16,157
New +$1.91M 2.24% 9

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Raleigh Capital Management's ABBV Position: Q1 2026 in Review

Raleigh Capital Management increased its AbbVie (ABBV) stake by 1.2% in Q1 2026, buying an estimated $39K and bringing the position to 15,361 shares worth $3.34M. The position accounts for 1.15% of the portfolio, ranked #16.

Raleigh Capital Management first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.9M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Raleigh Capital Management held 15,361 shares of AbbVie worth $3.34M as of Q1 2026.
  • Raleigh Capital Management bought 176 AbbVie shares in Q1 2026, an estimated $39K.
  • AbbVie made up 1.15% of Raleigh Capital Management's portfolio in Q1 2026, its #16 holding.
  • Raleigh Capital Management first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • Raleigh Capital Management's AbbVie position peaked at $3.9M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Raleigh Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.